The Evaluation of Clinical Manifestations of Maternal and Neonates in Covid-19-Infected Pregnant Women Referred to Amir Al-Almomenin Ali Hospital in Zabol

Determining the clinical manifestations of COVID-19 in pregnant and recently pregnant women is important to identify risk factors in order to evaluate complications and maternal and perinatal outcomes. The aim of the present study was to investigate the symptoms of COVID-19 in pregnant women and its effects on the newborn.

The Now study was a prospective descriptive study. This research was conducted in 2020 on 101 pregnant women with COVID-19 infection admitted to the intensive care unit in Zabol city, Iran. All studied patients were examined in terms of clinical symptoms, maternal and neonatal complications, and laboratory findings such as WBC and ESR in all patients were checked. Finally, all information was entered into each patient's form and by using SPSS V22 software analyzed.

Number of 101 pregnant women participated in the study, with an average age of 31.09 years. In this study, 93 individuals had PCR positive (92.1%), 84 individuals with COVID+ in CT scan (83.2%), 25 individuals with an underlying disease (24.8%), and 54 individuals with addiction (53.5%). 20 feet (19.8%) were reported. 20 deaths (19.8%) were reported. The average BMI of the participants was 25.46. Among maternal complications, pulmonary involvement (71.28%) the most frequently was reported. Among the hospitalized patients (95 individuals), 25 individuals had underlying diseases. In this population, maternal complications were significantly more reported (P value=0.012). Among neonatal complications, the most common cases of death were IUFD and abortion. 62.1% of the participants had a natural delivery and 63.4% had a term delivery.

Fever, throat redness and swelling, respiratory distress and cough are the most common clinical symptoms and lung involvement is the most common complication of COVID infection in pregnant mothers. In infants, IUFD and abortion were also very common. PCR and CT scan are two high-sensitivity tests for detecting COVID.